Your Gateway to Global News
News Updates
Do not worry we don't spam!
World
Jazz Pharmaceuticals has posted fresh phase 2 data on zanidatamab that show the HER2-targeted bispecific antibody kept 59% of people...
A targeted immunotherapy being developed by the biotech iTeos Therapeutics and GSK delivered promising response rates in patients with a...
Stay Tuned With Updates